The Form 4 filing, a report of an insider’s stock transactions, was filed on Nov. 18, 2026. The sale took place two days earlier, on Nov. 16. Dennis Cho serves as Twist Bioscience Corp’s senior vice president, chief legal officer and corporate secretary.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-16 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 5,427 |
| Price | $103.69 |
| Total Transaction Value | $562,714.78 |
| Insider | |
| Ticker Symbol | TWST |
| Company | Twist Bioscience Corp |
| Insider Name | Cho Dennis |
| Insider Title | Senior Vice President, Chief Legal Officer & Corporate Secretary |
| Sector - Industry | Healthcare - Biotechnology |
| Holdings | |
| Total Shares Owned After Transaction | 80,238 |
| Position Size Change | 6.34% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was one sale of TWST shares, reported with transaction code S. That code identifies shares sold, rather than shares withheld or delivered to cover a payment.
What was the average price of the transaction?
The average sale price was $103.688 per share. This rounds to $103.69 per share.
How did this transaction affect the insider's holdings?
Dennis Cho sold 5,427 shares and reported owning 80,238 shares afterward. The sale represented 6.34% of the shares he owned before the trade.
What's the total transaction value?
The total sale value was $562,714.78, rounded to cents from $562,714.776. That value covers all 5,427 shares in the one reported transaction.
Are there any special circumstances around this transaction?
The sale was identified as possibly tied to tax payments or the cost of exercising a stock option. A stock option gives someone the right to buy shares at a set price. Exercising it means using that right. No filing footnote text was provided, so the exact payment purpose is unknown. The available details do not establish that taxes were the only purpose.
For research purposes only; not investment advice.